Clinical Trial: Low Intensity Shockwave Therapy for Erectile Dysfunction


It is estimated that about 1 in 10 men suffer from erectile dysfunction (ED). Ryan P. Smith, MD, UVA urologist, is leading a clinical trial to test low-intensity shockwave therapy as a potential treatment for ED

Who is eligible to participate?

  • Men who currentlv suffer from ED
  • Patients who have undergone treatment for prostate cancer and have ED.
  • Patients who are planning to undergo treatment for prostate cancer and either have or are at risk for ED.

What can participants expect?

Participants will be randomly assigned to either a group that receives shockwave therapy or one that does not (the control group). Those in the control group will have the opportunity to receive shockwave therapy after the one-month follow-up appointment.

For those receiving therapy as part of the clinical trial, shockwaves will be delivered to the penis tissue twice a week for three weeks.

The full length of the study is six months. All appointments last about 30 minutes.

What will participants be required to do?

  • Fill out a questionnaire at the beginning and then again one month, three months, and six months after enrollment.
  • Have bi-weekly appointments for weeks one, two, and three of the study.
  • Have three follow-up appointments throughout the study: One month, three months and six months after enrollment

For more information contact:

Ryan P. Smith, MD or Lofton Neal, Clinical Research Coordinator